Generic Beclovent Inhaler (Beclate Inhaler) – Product Information
Generic Beclovent Inhaler (Beclate Inhaler, manufactured by Cipla) is used to prevent symptoms such as wheezing, shortness of breath, coughing, and chest tightness caused by asthma and other lung diseases in patients 5 years of age and older. Asthma causes the lining of thelungs to become inflamed (red and swollen), making it difficult to breathe. Beclomethasone Dipropionate works by reducing the inflammation in your airways. This helps to improve the patient's condition and to prevent asthma attacks from occurring. It is also used in the maintenance treatment of asthma as well as for asthma patients who require systemic corticosteroid administration to reduce or eliminate the need for the systemic corticosteroids.
The active ingredient present in Generic Beclovent Inhaler is Beclometasone Dipropionate.
Beclometasone Dipropionate inhaler is also marketed under trade names such as Beclovent Inhaler, Vanceril, Clenil, Asmabec Clickhaler, Beclate Inhaler, Clenil Modulite, Qvar and Easyhaler Beclometasone Dipropionate. It is also marketed as a nasal spray (e.g. Beconase, alanase, Vancenase) or nasal aerosol (e.g. Qnasl).
Dosage And Administration
Generic Beclovent Inhaler (Beclate Inhaler) comes as an aerosol to inhale by mouth. Each actuation delivers Beclomethasone Dipropionate IP 100 mcg suspended in CFC-free propellant in case of a BECLATE-100 Inhaler and 200 mcg in case of a BECLATE-200 Inhaler . Beclate Inhaler is manufactured by Cipla Ltd. Mumbai, India. Each Beclate inhaler contains 200 metered doses. The recommended adult dosage of Generic Beclovent Inhaler for adults is given below:
Adults and children over 12 years of age:-
Patients should be given a starting dose of inhaled Beclometasone Dipropionate which is appropriate for the severity of their disease based on the following guidance:
Mild asthma: 200 to 600mcg per day in divided doses.
Moderate asthma: 600 to 1000mcg per day in divided doses.
Severe asthma: Up to 1000mcg per day in divided doses.
The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to the individual response.
Children over 7 years of age:-
Up to 200mcg per day in divided doses.
Children should be given a starting dose of inhaled beclometasone dipropionate which is appropriate for the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to the individual response.
Generic Beclovent Inhaler (Beclate Inhaler) - Contraindications
Generic Beclovent Inhaler is contraindicated for patients with hypersensitivity to Beclometasone Dipropionate or any of the inactive ingredients present in Beclate Inhaler.
Generic Beclovent Inhaler is also contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
Generic Beclovent Inhaler (Beclate Inhaler) - Warnings and Precautions
When undergoing treatment with Generic Beclovent Inhaler the below mentioned precautions have to be noted:
- Patients have to be monitored periodically for signs of adverse effects on the oral cavity as Candida albicans infection of the mouth and throat may occur.
- Generic Beclovent Inhaler should not be used for relief of acute symptoms.
- There is a risk of impaired adrenal function when transferring patients from systemic corticosteroids.
- There exists a risk of potential worsening of existing tuberculosis, fungal, bacterial, viral, or parasitic infection; or ocular herpes simplex infections. More serious or even fatal course of chickenpox or measles can occur in susceptible patients.
- Bronchospasm, (Paradoxical Bronchospasm) with an immediate increase in wheezing, may occur after dosing.
- Hypersensitivity reactions, such as urticaria, angioedema, rash, and bronchospasm may occur. Discontinue Beclate Inhaler in case such reactions occur.
- Hypercorticism and adrenal suppression may occur with very high dosages or at the regular dosage in susceptible individuals. In case such changes occur, discontinue Beclate Inhaler slowly.
- Growth of pediatric patients has to be monitored for adverse effects of Generic Beclovent Inhaler.
- Patients with major risk factors for decreased bone mineral content have to be monitored.
- Patients with change in vision or with a history of increased intraocular pressure, glaucoma, and/or cataracts have to be closely monitored.
Side Effects of Generic Beclovent Inhaler (Beclate Inhaler)
The common side effects reported in patients treated with Generic Beclovent Inhaler (Beclate Inhaler) include headache, pharyngitis, oral symptoms (inhalation route), occasional cough upon inhalation, and sinusitis. Deposition on the tongue and throat may promote oral candidiasis, which appears as a white coating, possibly with irritation (usually prevented by rinsing the mouth with water after using the inhaler). Other side effects may rarely include: a smell similar to burning plastic, unpleasant taste, hoarseness or nasal congestion, pain or headache and visual changes. Allergic reactions may occur, but rarely.
More Details
For more details on Generic Beclovent please watch the presentation below.
